Adolescent understanding and acceptance of the HPV vaccination in an underserved population in New York City

Jill Blumenthal, Melissa K. Frey, Michael J. Worley, Nana E. Tchabo, Karen Soren, Brian Slomovitz

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background. HPV vaccination may prevent thousands of cases of cervical cancer. We aimed to evaluate the understanding and acceptance of the HPV vaccine among adolescents. Methods. A questionnaire was distributed to adolescents at health clinics affiliated with a large urban hospital system to determine knowledge pertaining to sexually transmitted diseases and acceptance of the HPV vaccine. Results. 223 adolescents completed the survey. 28 were male, and 70 were female. The mean age for respondents was 16 years old. Adolescents who had received the HPV vaccine were more likely to be female and to have heard of cervical cancer and Pap testing. Of the 143 adolescents who had not yet been vaccinated, only 4 believed that they were at risk of HPV infection and 52 were willing to be vaccinated. Conclusions. Surveyed adolescents demonstrated a marginal willingness to receive the HPV vaccine and a lack of awareness of personal risk for acquiring HPV.

Original languageEnglish (US)
Article number904034
JournalJournal of Oncology
DOIs
StatePublished - 2012
Externally publishedYes

Fingerprint

Vulnerable Populations
Papillomavirus Vaccines
Vaccination
Uterine Cervical Neoplasms
Urban Hospitals
Sexually Transmitted Diseases
Infection
Surveys and Questionnaires

ASJC Scopus subject areas

  • Oncology

Cite this

Adolescent understanding and acceptance of the HPV vaccination in an underserved population in New York City. / Blumenthal, Jill; Frey, Melissa K.; Worley, Michael J.; Tchabo, Nana E.; Soren, Karen; Slomovitz, Brian.

In: Journal of Oncology, 2012.

Research output: Contribution to journalArticle

Blumenthal, Jill ; Frey, Melissa K. ; Worley, Michael J. ; Tchabo, Nana E. ; Soren, Karen ; Slomovitz, Brian. / Adolescent understanding and acceptance of the HPV vaccination in an underserved population in New York City. In: Journal of Oncology. 2012.
@article{32af4b9d095e4ed289703a62c7c42e67,
title = "Adolescent understanding and acceptance of the HPV vaccination in an underserved population in New York City",
abstract = "Background. HPV vaccination may prevent thousands of cases of cervical cancer. We aimed to evaluate the understanding and acceptance of the HPV vaccine among adolescents. Methods. A questionnaire was distributed to adolescents at health clinics affiliated with a large urban hospital system to determine knowledge pertaining to sexually transmitted diseases and acceptance of the HPV vaccine. Results. 223 adolescents completed the survey. 28 were male, and 70 were female. The mean age for respondents was 16 years old. Adolescents who had received the HPV vaccine were more likely to be female and to have heard of cervical cancer and Pap testing. Of the 143 adolescents who had not yet been vaccinated, only 4 believed that they were at risk of HPV infection and 52 were willing to be vaccinated. Conclusions. Surveyed adolescents demonstrated a marginal willingness to receive the HPV vaccine and a lack of awareness of personal risk for acquiring HPV.",
author = "Jill Blumenthal and Frey, {Melissa K.} and Worley, {Michael J.} and Tchabo, {Nana E.} and Karen Soren and Brian Slomovitz",
year = "2012",
doi = "10.1155/2012/904034",
language = "English (US)",
journal = "Journal of Oncology",
issn = "1687-8450",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Adolescent understanding and acceptance of the HPV vaccination in an underserved population in New York City

AU - Blumenthal, Jill

AU - Frey, Melissa K.

AU - Worley, Michael J.

AU - Tchabo, Nana E.

AU - Soren, Karen

AU - Slomovitz, Brian

PY - 2012

Y1 - 2012

N2 - Background. HPV vaccination may prevent thousands of cases of cervical cancer. We aimed to evaluate the understanding and acceptance of the HPV vaccine among adolescents. Methods. A questionnaire was distributed to adolescents at health clinics affiliated with a large urban hospital system to determine knowledge pertaining to sexually transmitted diseases and acceptance of the HPV vaccine. Results. 223 adolescents completed the survey. 28 were male, and 70 were female. The mean age for respondents was 16 years old. Adolescents who had received the HPV vaccine were more likely to be female and to have heard of cervical cancer and Pap testing. Of the 143 adolescents who had not yet been vaccinated, only 4 believed that they were at risk of HPV infection and 52 were willing to be vaccinated. Conclusions. Surveyed adolescents demonstrated a marginal willingness to receive the HPV vaccine and a lack of awareness of personal risk for acquiring HPV.

AB - Background. HPV vaccination may prevent thousands of cases of cervical cancer. We aimed to evaluate the understanding and acceptance of the HPV vaccine among adolescents. Methods. A questionnaire was distributed to adolescents at health clinics affiliated with a large urban hospital system to determine knowledge pertaining to sexually transmitted diseases and acceptance of the HPV vaccine. Results. 223 adolescents completed the survey. 28 were male, and 70 were female. The mean age for respondents was 16 years old. Adolescents who had received the HPV vaccine were more likely to be female and to have heard of cervical cancer and Pap testing. Of the 143 adolescents who had not yet been vaccinated, only 4 believed that they were at risk of HPV infection and 52 were willing to be vaccinated. Conclusions. Surveyed adolescents demonstrated a marginal willingness to receive the HPV vaccine and a lack of awareness of personal risk for acquiring HPV.

UR - http://www.scopus.com/inward/record.url?scp=84855592087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855592087&partnerID=8YFLogxK

U2 - 10.1155/2012/904034

DO - 10.1155/2012/904034

M3 - Article

C2 - 22187557

AN - SCOPUS:84855592087

JO - Journal of Oncology

JF - Journal of Oncology

SN - 1687-8450

M1 - 904034

ER -